Thinle Chodon

7.4k total citations · 3 hit papers
33 papers, 5.2k citations indexed

About

Thinle Chodon is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Thinle Chodon has authored 33 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 18 papers in Immunology and 13 papers in Molecular Biology. Recurrent topics in Thinle Chodon's work include Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (12 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Thinle Chodon is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), CAR-T cell therapy research (12 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Thinle Chodon collaborates with scholars based in United States, Australia and Japan. Thinle Chodon's co-authors include Antoni Ribas, Richard C. Koya, Roger S. Lo, Hubing Shi, Xiangju Kong, Jeffrey A. Sosman, Mi‐Kyung Lee, Stanley F. Nelson, Hane Lee and Narsis Attar and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Thinle Chodon

33 papers receiving 5.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

2010 1.6k citations Ramin Nazarian, Hubing Shi et al. Nature profile →
Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy

2013 715 citations Hubing Shi, Willy Hugo et al. Cancer Discovery profile →
Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance

2012 470 citations Hubing Shi, Gatien Moriceau et al. Nature Communications profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Thinle Chodon	3.3k	3.2k	1.4k	578	527	33	5.2k
Willy Hugo	2.5k 0.8×	2.4k 0.8×	1.4k 1.0×	334 0.6×	369 0.7×	44	4.3k
Bartosz Chmielowski	2.6k 0.8×	4.4k 1.4×	1.8k 1.3×	319 0.6×	538 1.0×	180	7.0k
James S. Wilmott	2.8k 0.9×	4.4k 1.4×	2.4k 1.7×	210 0.4×	282 0.5×	139	6.4k
David Hogg	3.3k 1.0×	4.0k 1.2×	1.2k 0.8×	192 0.3×	540 1.0×	124	6.3k
Nathalie Dhomen	2.2k 0.7×	1.6k 0.5×	474 0.3×	318 0.6×	375 0.7×	34	3.2k
Kimberly B. Dahlman	2.3k 0.7×	1.7k 0.5×	451 0.3×	401 0.7×	488 0.9×	38	3.2k
Nageatte Ibrahim	2.3k 0.7×	4.7k 1.5×	1.8k 1.3×	133 0.2×	253 0.5×	82	5.8k
María Romina Girotti	1.6k 0.5×	1.4k 0.4×	827 0.6×	146 0.3×	227 0.4×	44	3.0k
Begonya Comin-Anduix	1.7k 0.5×	2.6k 0.8×	2.1k 1.5×	110 0.2×	220 0.4×	42	4.3k
Ester Simeone	1.5k 0.4×	3.2k 1.0×	1.6k 1.2×	152 0.3×	167 0.3×	114	4.4k

Countries citing papers authored by Thinle Chodon

Since Specialization

Citations

This map shows the geographic impact of Thinle Chodon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thinle Chodon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thinle Chodon more than expected).

Fields of papers citing papers by Thinle Chodon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thinle Chodon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thinle Chodon. The network helps show where Thinle Chodon may publish in the future.

Co-authorship network of co-authors of Thinle Chodon

This figure shows the co-authorship network connecting the top 25 collaborators of Thinle Chodon. A scholar is included among the top collaborators of Thinle Chodon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thinle Chodon. Thinle Chodon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Withers, Henry, Junko Matsuzaki, Mark D. Long, et al.. (2025). mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors. Journal for ImmunoTherapy of Cancer. 13(3). e010408–e010408. 2 indexed citations

Tsuji, Takemasa, Junko Matsuzaki, Hemn Mohammadpour, et al.. (2022). Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction. Cancer Immunology Immunotherapy. 71(12). 2881–2898. 4 indexed citations

Matsueda, Satoko, Thinle Chodon, & Richard C. Koya. (2019). Cellular Immunotherapy in the Treatment of Hematopoietic Malignancies. Advances in experimental medicine and biology. 1143. 217–229. 3 indexed citations

Ribas, Antoni, Daniel Sanghoon Shin, Jesse M. Zaretsky, et al.. (2016). PD-1 Blockade Expands Intratumoral Memory T Cells. Cancer Immunology Research. 4(3). 194–203. 302 indexed citations

Chodon, Thinle, Richard C. Koya, & Kunle Odunsi. (2015). Active Immunotherapy of Cancer. Immunological Investigations. 44(8). 817–836. 40 indexed citations

Gschweng, Eric H., Melissa McCracken, Michael L. Kaufman, et al.. (2014). HSV-sr39TK Positron Emission Tomography and Suicide Gene Elimination of Human Hematopoietic Stem Cells and Their Progeny in Humanized Mice. Cancer Research. 74(18). 5173–5183. 26 indexed citations

Wong, Deborah J., Earl Avramis, Douglas Matsunaga, et al.. (2014). Exposure to a Histone Deacetylase Inhibitor Has Detrimental Effects on Human Lymphocyte Viability and Function. Cancer Immunology Research. 2(5). 459–468. 17 indexed citations

Atefi, Mohammad, Earl Avramis, Amanda Lassen, et al.. (2014). Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma. Clinical Cancer Research. 20(13). 3446–3457. 285 indexed citations

Robert, Lídia, Jennifer Tsoi, Xiaoyan Wang, et al.. (2014). CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire. Clinical Cancer Research. 20(9). 2424–2432. 280 indexed citations

10.

Shi, Hubing, Aayoung Hong, Xiangju Kong, et al.. (2013). A Novel AKT1 Mutant Amplifies an Adaptive Melanoma Response to BRAF Inhibition. Cancer Discovery. 4(1). 69–79. 133 indexed citations

11.

Shi, Hubing, Willy Hugo, Xiangju Kong, et al.. (2013). Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy. Cancer Discovery. 4(1). 80–93. 715 indexed citations breakdown →

12.

Ma, Chao, Ann Cheung, Thinle Chodon, et al.. (2013). Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy. Cancer Discovery. 3(4). 418–429. 112 indexed citations

13.

Koya, Richard C., Stephen Mok, Nicholas Otte, et al.. (2012). BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy. Cancer Research. 72(16). 3928–3937. 187 indexed citations

14.

Shi, Hubing, Gatien Moriceau, Xiangju Kong, et al.. (2012). Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance. Nature Communications. 3(1). 724–724. 470 indexed citations breakdown →

15.

Ma, Chao, Rong Fan, Habib Ahmad, et al.. (2011). A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells. Nature Medicine. 17(6). 738–743. 356 indexed citations

16.

Koya, Richard C., Stephen Mok, Begoña Comı́n-Anduix, et al.. (2010). Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses. Proceedings of the National Academy of Sciences. 107(32). 14286–14291. 48 indexed citations

17.

Nazarian, Ramin, Hubing Shi, Qi Wang, et al.. (2010). Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature. 468(7326). 973–977. 1614 indexed citations breakdown →

18.

Euw, Erika von, Thinle Chodon, Narsis Attar, et al.. (2009). CTLA4 blockade increases Th17 cells in patients with metastatic melanoma. Journal of Translational Medicine. 7(1). 35–35. 135 indexed citations

19.

Furukawa, Hiroshi, Hisakazu Fujita, Yuichiro Yamamoto, et al.. (2002). Identification of a novel gelsolin truncate in the vertical and metastatic phase malignant melanomas. Melanoma Research. 12(6). 523–528. 4 indexed citations

20.

Chodon, Thinle, Tsuneki Sugihara, Hiroharu H. Igawa, Emi Funayama, & Hiroshi Furukawa. (2000). Keloid-Derived Fibroblasts Are Refractory to Fas-Mediated Apoptosis and Neutralization of Autocrine Transforming Growth Factor-β1 Can Abrogate this Resistance. American Journal Of Pathology. 157(5). 1661–1669. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact